Biosystems modelling for in silico target validation: Challenges to implementation

Expert Opinion on Therapeutic Targets

Volumn 4, Issue 6, 2000, Pages 699-714

  Ho, Richard Li Xiang ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

biological systems modelling; cellular automata; computer simulation; diffusion of innovation; disease modelling; implementation; in silico target validation; top down modelling

Indexed keywords

EID: 0010629999     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.4.6.699     Document Type: Article

References (46)

1. SABBAGH K: 21st-Century Jet. Scribner, NY, USA (1996).
2. ROSES AD: Pharmacogenetics and the practice of medicine. Nature (2000) 405:857-865.
3. KENNEDY T: Managing the drug discovery/development interface. Drug Disc. Today (1997) 2 (10):436-444.
4. CALDWELL GW: Compound optimization in early-and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitroand in vivoscreens. Curr Opin. DrugDisc. Devel. (2000) 3 (1):30-41.
5. HARRIS G: Drug firms, stymied in the lab, become marketing machines. The Wall Street Journal (2000) 236:A1, A12.
6. DREWS J: In Quest of Tomorrow's Medicines. Springer-Verlag, NY, USA (1999):203.
7. BURSTALL ML, REUBEN BG: Outlook for the World Pharmaceutical Industry to 2010. Decision Resources (Dec 1999) R4172.
8. GOLUB TR, SLONIM DK, TAMAYO P et al: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 286:531-537.
9. FURNESS LM, HENRICHWARK S, EGERTON M: Expres sion databases-resources for pharmacogenomic R&D. Pharmacogenomics (2000) 1 (3):281-288.
10. JAIN KK: Transforming innovation and commercialization in drug discovery. Drug Disc. Today (2000) 5:318-320.
11. LIFTON RP: Molecular genetics of human blood pressure variation. Science (1996) 272 (5262):676-80.
12. KACSERH, BURNS JA: The control of flux. Symp. Soc. Exp. Biol. (1973) 27:65-104.
13. HEINRICH R, RAPOPORT TA: A linear steady-state treatment of enzymatic chains. Critique of the crossover theorem and a general procedure to identify interaction sites with an effector. Eur. J. Biochem. (1974) 42:89-95.
14. CORNISH-BOWDEN A: Metabolic control analysis in biotechnology and medicine. Nature Biotechnol. (1999) 17:641-643.
15. SERESSIOTIS A, BAILEY JE: MPS: an artificially intelligent software system for the analysis and synthesis of metabolic pathways. Biotechnol. Bioeng. (1988) 31:587-602.
16. SCHILLING CH, EDWARDS JS, PALSSON BO: Toward metabolic phenomics: analysis of genomic data using flux balances. Biotechnol. Prog. (1999) 15:288-295.
17. NOBLE D, COLATSKY TJ: A return to rational drug discovery: computer-based models of cells, organs and systems in drug target identification. Emerging Therapeutic Targets (2000) 4(1):39-49.
18. EDWARDS JS, PALSSON BO: Systems properties of the Haemophilus influenzae Rd metabolic genotype. J. Biol. Chem. (1999) 274:17410-17416.
19. SCHILLING CH, PALSSON BO: The underlying pathway structure of biochemical reaction networks. Proc. Natl. Acad. Sci. USA (1998) 95:4193-4198.
20. MULQUINEY PJ, KUCHEL PW: Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: computer simulation and metabolic control analysis. Biochem. J. (1999) 342 (Pt 3):597-604.
21. KAUFFMAN S: At Home in the Universe. Oxford University Press, NY, USA (1995).
22. MOSIER D, SIEBURG H: Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol. Today (1994) 15(7):332-339.
23. GONG DA, MONEMDJOU S, GAVRILOVA O etal: Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J. Biol. Chem. (2000) 275 (21):16251-16257.
24. GOLDRATT EM, COX J: The Goal: A Process of Ongoing Improvement. North River Press, Great Barrington, MA, USA (1992).
25. CHRISTENSEN C, OVERDORF M: Meeting the challenge of disruptive change. Harvard Business Review (Mar-Apr 2000):66-76.
26. VOIT EO, SAVAGEAU MA: A primer on metabolic pathway analysis. Intelligent Systems for Molecular Biology 2000. San Diego, USA (19 August 2000).
27. HARTL DL, OREL V: What did Gregor Mendel think he discovered? Genetics (1992) 131:245-253.
28. DRAZEN JM, STOKES C: Managing the complexity of asthma. American Thoracic Society, 96th International Conference. Toronto, Canada (8 May 2000).
29. INNES C, WHITE N: IL-4 receptor-a breath of fresh air for asthmatics? Inpharma (2000) 1231:7-8.
30. This reference is also available on the web: http://www.adis.com/ newsletters/inpharma/articles/763450.html
31. KUHN TS: The Structure of Scientific Revolutions (2nd edition). University of Chicago Press, Chicago, USA (1970).
32. CHRISTENSEN CM: The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail. Harvard Business School Press, Boston, USA (1997).
33. TUFTE ER: Visual Explanations. Graphics Press, Cheshire, CT, USA (1997).
34. ZALTMAN G, DUNCAN R, HOLBECK J: Innovations and Organizations. Wiley and Sons, NY, USA (1973).
35. KOTTER JP: Leading Change. Harvard Business School Press, Cambridge, MA, USA (1996).
36. ROGERS EM: Diffusion of Innovations (4th edition). The Free Press, NY, USA (1995):397.
37. MOORE GA: Crossing the Chasm (revised edition). Harper-Business, New York, USA (1999).
38. KLEIN G: Sources of Power. MIT Press, Cambridge, MA, USA (1999).
39. GOLDRATT EM: Critical Chain. North River Press, Great Barrington, MA, USA (1997).
40. SCHRAGE M: Serious Play. Harvard Business School Press, Boston, USA (2000).
41. ALIZADEH, EISEN MB, DAVIS RE et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 403 (6769):503-511.
42. CHRISTENSEN CM, BOHMER R, KENAGY J: Will disruptive innovations cure health care? Harvard Business Review (Sep-Oct 2000):102-111.
43. ZIPKIN I: Entelos: simulating disease. BioCentury (5 Oct 1998):A9.
44. DINERSTEIN RJ, PATERSON TS: The Asthma PhysioLab: a software environment designed to simulate asthma disease processes for drug discovery and develop ment. Drug Discovery Technology 2000. Boston, MA, USA (16 Aug 2000).
45. FINK PK, MORGAN K: Evolving an understanding of gene expression data resulting from oxidative stress. In Silico Biology. San Francisco, USA (21 June 2000).
46. HO RLX: Integrating traditional and in silico approaches for diabetes target triage. In Silico Biology. San Francisco, USA (22 June 2000).